130
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Based on what parameters is safe to discontinuate inhaled corticosteroids in children with asthma?

, PhDORCID Icon & , PhDORCID Icon
Pages 2121-2129 | Received 20 Apr 2023, Accepted 27 May 2023, Published online: 20 Jun 2023

References

  • Von Mutius E. Progression of allergy and asthma through childhood to adolescence. Thorax. 1996;51(Suppl 1):S3–S6. doi:10.1136/thx.51.Suppl_1.S3.
  • Gershon A, Guan J, Victor JC, Wang C, To T. The course of asthma activity: a population study. J Allergy Clin Immunol. 2012;129(3):679–686. doi:10.1016/j.jaci.2011.11.014.
  • Braman SS. Growing old with asthma: what are the changes and challenges. Expert Rev Respir Med. 2010;4(2):239–248. doi:10.1586/ers.10.12.
  • Morgan WJ, Stern DA, Sherrill DL, Guerra S, Holberg CJ, Guilbert TW, Taussig LM, Wright AL, Martinez FD. Outcome of asthma and wheezing in the first 6 years of life. Follow-up through adolescence. Am J Respir Crit Care Med. 2005;172(10):1253–1258. doi:10.1164/rccm.200504-525OC.
  • Bateman ED, Bousquet J, Busse WW, Clark TJ, Gul N, Gibbs M, Pedersen S, GOAL Steering Committee and Investigators. Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy. 2008;63(7):932–938. doi:10.1111/j.1398-9995.2008.01724.x.
  • Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32(3):545–554. doi:10.1183/09031936.00155307.
  • Upham JW, James AL. Remission of asthma: the next therapeutic frontier? Pharmacol Ther. 2011;130(1):38–45. doi:10.1016/j.pharmthera.2011.01.002.
  • Asher I, Pearce N. Global burden of asthma among children. Int J Tuberc Lung Dis. 2014;18(11):1269–1278. doi:10.5588/ijtld.14.0170.
  • National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Quick reference for the NAEPP Expert Panel Report: guidelines for the diagnosis and management of asthma–Update on selected topics 2002. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 2002. Publication no. 02-5075. Available at http://www.nhlbi.nih.gov/guidelines/asthma/index.htm.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention 2011. Available from: https://ginasthma.org/archived-reports/.
  • Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, Dixon AE, Elward KS, Hartert T, Krishnan JA, Lemanske RFJr, Ouellette DR, Pace WD, Schatz M, Skolnik NS, Stout JW, Teach SJ, Umscheid CA, Walsh CG. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146(6):1217–1270. doi:10.1016/j.jaci.2020.10.003. Erratum in: J Allergy Clin Immunol. 2021;147(4):1528–1530.
  • Global Initiative for Asthma. Global Strategy for asthma management and prevention – Update 2015. Available from: https://ginasthma.org/archived-reports/.
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2022. Available from: www.ginasthma.org.
  • Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, Szefler SJ, Woodruff PG, de Giorgio-Miller A, Trudo F, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145(3):757–765. doi:10.1016/j.jaci.2019.12.006.
  • Carpaij OA, Burgess JK, Kerstjens HAM, Nawijn MC, van den Berge M. A review on the pathophysiology of asthma remission. Pharmacol Ther. 2019;201:8–24. doi:10.1016/j.pharmthera.2019.05.002.
  • Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, Willems LN, Sterk PJ. Relation between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled corticosteroids. Thorax. 1996;51(5):496–502. doi:10.1136/thx.51.5.496.
  • Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998;157(1):4–9. doi:10.1164/ajrccm.157.1.9703002.
  • Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodeling. Eur Respir J. 1999;14(1):63–73. doi:10.1034/j.1399-3003.1999.14a12.x.
  • Global Initiative for Asthma: Global Strategy for Asthma Managment and Prevention. NHLBI/WHO Workshop Report, Updated 2003. London: Global Initiative for Asthma; November 2003. Available at: gina workshop report Final (ginasthma.org)
  • Sears MR, Herbison GP, Holdaway MD, Hewitt CJ, Flannery EM, Silva PA. The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy. 1989;19(4):419–424. doi:10.1111/j.1365-2222.1989.tb02408.x.
  • Skin tests used in type I allergy testing position paper. Sub-committee on skin tests of the European Academy of Allergology and Clinical Immunology. Allergy. 1989;44:1–59.
  • Standardization of spirometry: 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107–1136.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, ATS/ERT Task Force, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
  • Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al. Standardization of s 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST.
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205.
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2014. Available from: https://ginasthma.org/archived-reports/.
  • Schulze J, Rosewich M, Riemer C, Dressler M, Rose MA, Zielen S. Methacholine challenge – comparison of an ATS protocol to a new rapid single concentration techniqwue. Respir Med. 2009;103(12):1898–1903. doi:10.1016/j.rmed.2009.06.007.
  • de Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O, Carrozzi L, Dallari R, Giammanco G, Ginesu F, ISAYA study group, et al. The control of asthma in Italy. A multicenter descriptive study on young adults with the doctor diagnosed current asthma. Allergy. 2003;58(3):221–228. doi:10.1034/j.1398-9995.2003.00059.x.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention NHLBI/WHO workshop report. Bethesda (MD): National Institutes of Health. National Heart Lung and Blood Institute publication; 2006. Report No. 02-3659.
  • Rank MA, Hagan JB, Park MA, Podjasek JC, Samant SA, Volcheck GW, Erwin PJ, West CP. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomised controlled trials. J Allergy Clin Immunol. 2013;131(3):724–729. doi:10.1016/j.jaci.2012.11.038.
  • Horak E, Lanigan A, Roberts M, Welsh L, Wilson J, Carlin JB, Olinsky A, Robertson CF. Longitudinal study of childhood wheezy bronchitis and asthma:outcome at the age 42. BMJ. 2003;326(7386):422–423. doi:10.1136/bmj.326.7386.422.
  • Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R. A longitudinal, population based cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349(15):1414–1422. doi:10.1056/NEJMoa022363.
  • Broekema M, Volbeda F, Timens W, Dijkstra A, Lee NA, Lee JJ, Lodewijk ME, Postma DS, Hylkema MN, ten Hacken NH. Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1). Respir Med. 2010;104(9):1254–1262. doi:10.1016/j.rmed.2010.03.030.
  • Sumino K, Sugar EA, Irvin CG, Kaminsky DA, Shade D, Wei CY, Holbrook JT, Wise RA, Castro M, American Lung Association Asthma Clinical Research Centers. Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol. 2012;130(1):69–75.e6. doi:10.1016/j.jaci.2012.02.025.
  • Taylor DR, Cowan JO, Greene JM, Willan AR, Sears MR. Asthma in remission: can relapse in early adulthood be predicted at 18 years of age? Chest. 2005;127(3):845–850. doi:10.1378/chest.127.3.845.
  • Wang AL, Datta S, Weiss ST, Tantisira KG. Remission of persistent childhood asthma: early predictors of adult outcomes. J Allergy Clin Immunol. 2019;143(5):1752–1759.e6. doi:10.1016/j.jaci.2018.09.038.
  • Vonk JM, Postma DS, Boezen HM, Grol MH, Schouten JP, Koëter GH, Gerritsen J. Childhood factors associated with asthma remission after 30 year follow up. Thorax. 2004;59(11):925–929. doi:10.1136/thx.2003.016246.
  • Yoo Y, Yu J, Kim DK, Koh YY. Percentage fall in FVC at the provocative concentration of methacholine causing a 20% fall in FEV1 in symptomatic asthma and clinical remission during adolescence. Chest. 2006;129(2):272–277. doi:10.1378/chest.129.2.272.
  • Peat JK, Woolcock AJ. Sensitivity to common allergens: relation to respiratory symptoms and bronchial hyper-responsiveness in children from three different climatic areas of Australia. Clin Exp Allergy. 1991;21(5):573–581. doi:10.1111/j.1365-2222.1991.tb00849.x.
  • Dodge R, Burrows B, Lebowitz MD, Cline MG. Antecedent features of children in whom asthma develops during the second decade of life. J Allergy Clin Immunol. 1993;92(5):744–749. doi:10.1016/0091-6749(93)90018-b.
  • Wahn U, Lau S, Bergmann R, Kulig M, Forster J, Bergmann K, Bauer CP, Guggenmoos-Holzmann I. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol. 1997;99(6 Pt 1):763–769. doi:10.1016/s0091-6749(97)80009-7.
  • Roorda R, Gerritsen J, van Aalderen WM, Schouten JP, Veltman JC, Weiss ST, Knol K. Risk factors for the persistence of respiratory symptoms in childhood asthma. Am Rev Respir Dis. 1993;148(6 Pt 1):1490–1495. doi:10.1164/ajrccm/148.6_Pt_1.1490.
  • Withers NJ, Low L, Holgate ST, Clough JB. The natural history of respiratory symptoms in a cohort of adolescents. Am J Respir Crit Care Med. 1998;158(2):352–357. doi:10.1164/ajrccm.158.2.9705079.
  • Lewis S, Richards D, Bynner J, Butler N, Britton J. Prospective study of risk factors for early and persistent wheezing in childhood. Eur Respir J. 1995;8(3):349–356. doi:10.1183/09031936.95.08030349.
  • Teeter JG, Bleecker ER. Relation between airway obstruction and respiratory symptoms in adult asthmatics. Chest. 1998;113(2):272–277. doi:10.1378/chest.113.2.272.
  • Mochizuki H, Muramatsu R, Hagiwara S, Takami S, Mizuno T, Arakawa H. Relationship between bronchial hyperreactivity and asthma remission during adolescence. Ann Allergy Asthma Immunol. 2009;103(3):201–205. doi:10.1016/S1081-1206(10)60182-2.
  • van den Toorn LM, Overbeek SE, De Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med. 2001;164(11):2107–2113. doi:10.1164/ajrccm.164.11.2006165.
  • Warke TJ, Fitch PS, Brown V, Taylor R, Lyons JD, Ennis M, Shields MD. Outgrown asthma does not mean no airways inflammation. Eur Respir J. 2002;19(2):284–287. doi:10.1183/09031936.02.00882002.
  • Vanacker NJ, Palmans E, Kips JC, Pauwels RA. Fluticasone inhibits but does not reverse allergen-induced stuctural airway changes. Am J Respir Crit Care Med. 2001;163(3 Pt 1):674–679. doi:10.1164/ajrccm.163.3.2004160.
  • Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol. 1999;104(2 Pt 1):356–363. doi:10.1016/s0091-6749(99)70379-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.